+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
Oncology Markets for Tyrokinse Kinase Inhibitors - Product Thumbnail Image

Oncology Markets for Tyrokinse Kinase Inhibitors

  • Report
  • October 2021
  • 137 Pages
  • Global
From
Companion Diagnostics (CDx) Market Report 2024-2034 - Product Thumbnail Image

Companion Diagnostics (CDx) Market Report 2024-2034

  • Report
  • January 2024
  • 307 Pages
  • Global
From
From
Global Rare Hemophilia Factors Market 2022-2026 - Product Thumbnail Image

Global Rare Hemophilia Factors Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
  • Global
From
Global Breast Cancer Drug Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Breast Cancer Drug Market & Clinical Trial Insight 2025

  • Clinical Trials
  • January 2020
  • 1140 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator